Financial Performance - The company reported a basic earnings per share of 0.0500 yuan for Q1 2025, representing a 25% increase compared to 0.0400 yuan in Q1 2024, but a decrease from 0.1100 yuan in Q1 2023 [1] - The net profit for Q1 2025 was 0.71 billion yuan, a significant increase of 39.22% from 0.51 billion yuan in Q1 2024, but a decrease from 1.47 billion yuan in Q1 2023 [1] - The return on equity (ROE) improved to 0.98% in Q1 2025 from 0.72% in Q1 2024, but decreased from 2.10% in Q1 2023 [1] - The total revenue for Q1 2025 was 15.39 billion yuan, a 3.5% increase from 14.87 billion yuan in Q1 2024, but a decrease from 15.76 billion yuan in Q1 2023 [1] Shareholder Structure - The top ten unrestricted shareholders collectively hold 107,595.13 million shares, accounting for 80.56% of the circulating shares, with a decrease of 2,305.37 million shares compared to the previous period [1] - The largest shareholder, Lianhong Group Co., Ltd., holds 65,135.63 million shares, representing 48.77% of the total share capital, with a reduction of 2,327.81 million shares [2] - China Academy of Sciences Holdings Co., Ltd. remains unchanged with 33,748.00 million shares, accounting for 25.27% [2] Dividend Policy - The company has announced that it will not distribute dividends or transfer shares this time [3]
联泓新科:2025一季报净利润0.71亿 同比增长39.22%